Cytosolic GDH1 degradation restricts protein synthesis to sustain tumor cell survival following amino acid deprivation

EMBO J. 2021 Oct 18;40(20):e107480. doi: 10.15252/embj.2020107480. Epub 2021 Jul 16.

Abstract

The mTORC1 pathway plays key roles in regulating various biological processes, including sensing amino acid deprivation and driving expression of ribosomal protein (RP)-coding genes. In this study, we observed that depletion of glutamate dehydrogenase 1 (GDH1), an enzyme that converts glutamate to α-ketoglutarate (αKG), confers resistance to amino acid deprivation on kidney renal clear cell carcinoma (KIRC) cells. Mechanistically, under conditions of adequate nutrition, GDH1 maintains RP gene expression in a manner dependent on its enzymatic activity. Following amino acid deprivation or mTORC1 inhibition, GDH1 translocates from mitochondria to the cytoplasm, where it becomes ubiquitinated and degraded via the E3 ligase RNF213. GDH1 degradation reduces intracellular αKG levels by more than half and decreases the activity of αKG-dependent lysine demethylases (KDMs). Reduced KDM activity in turn leads to increased histone H3 lysine 9 and 27 methylation, further suppressing RP gene expression and preserving nutrition to support cell survival. In summary, our study exemplifies an economical and efficient strategy of solid tumor cells for coping with amino acid deficiency, which might in the future be targeted to block renal carcinoma progression.

Keywords: GDH1; amino acid deprivation; kidney cancer; ribosomes; αKG.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphatases / genetics
  • Adenosine Triphosphatases / metabolism
  • Animals
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / metabolism
  • Carcinoma, Renal Cell / mortality
  • Carcinoma, Renal Cell / pathology
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Cell Line, Tumor
  • DNA-Binding Proteins / antagonists & inhibitors
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Epithelial Cells / metabolism
  • Epithelial Cells / pathology
  • Female
  • Gene Expression Regulation, Neoplastic
  • Glutamate Dehydrogenase / antagonists & inhibitors
  • Glutamate Dehydrogenase / genetics*
  • Glutamate Dehydrogenase / metabolism
  • Glutamic Acid / metabolism*
  • Histone Demethylases / genetics
  • Histone Demethylases / metabolism
  • Humans
  • Jumonji Domain-Containing Histone Demethylases / genetics
  • Jumonji Domain-Containing Histone Demethylases / metabolism
  • Ketoglutaric Acids / metabolism*
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / metabolism
  • Kidney Neoplasms / mortality
  • Kidney Neoplasms / pathology
  • Mice
  • Mice, Nude
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism
  • Nuclear Proteins / antagonists & inhibitors
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Poly-ADP-Ribose Binding Proteins / genetics
  • Poly-ADP-Ribose Binding Proteins / metabolism
  • Protein Isoforms / genetics
  • Protein Isoforms / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Ribosomal Proteins / genetics
  • Ribosomal Proteins / metabolism
  • Signal Transduction
  • Survival Analysis
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Ketoglutaric Acids
  • Neoplasm Proteins
  • Nuclear Proteins
  • Poly-ADP-Ribose Binding Proteins
  • Protein Isoforms
  • RNA, Small Interfering
  • Ribosomal Proteins
  • TRIM27 protein, human
  • ribosomal protein L9
  • Glutamic Acid
  • Histone Demethylases
  • Jumonji Domain-Containing Histone Demethylases
  • KDM6A protein, human
  • Glutamate Dehydrogenase
  • GLUD1 protein, human
  • KDM4A protein, human
  • CHFR protein, human
  • RNF213 protein, human
  • Ubiquitin-Protein Ligases
  • Adenosine Triphosphatases

Associated data

  • GEO/GSE167514